Literature DB >> 30408018

Notes from the Field: Cronobacter sakazakii Meningitis in a Full-Term Neonate Fed Exclusively with Breast Milk - Indiana, 2018.

Madhura Sundararajan, Leslie A Enane, Laurie A Kidwell, Ryan Gentry, Stanley Danao, Samina Bhumbra, Christopher Lehmann, Megan Teachout, Jamie Yeadon-Fagbohun, Peter Krombach, Betsy Schroeder, Haley Martin, Jonathan Winkjer, Thomas Waltz, Jonathan Strysko, Jennifer R Cope.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30408018      PMCID: PMC6223960          DOI: 10.15585/mmwr.mm6744a7

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
In January 2018, the Indiana State Department of Health (ISDH) was notified of a case of Cronobacter sakazakii meningitis in a female neonate who had been fed exclusively maternal breast milk. The infant was born by induced vaginal delivery at 37 weeks’ gestational age. She was discharged from the newborn nursery after 2 days and was clinically well until age 8 days, when she was admitted with poor feeding, fever of 100.4°F (38°C), and abnormal movements. Electroencephalography demonstrated multifocal seizures; MRI demonstrated multifocal restricted diffusion, leptomeningeal enhancement, and patchy hemorrhagic areas. Cultures from blood and cerebrospinal fluid yielded C. sakazakii, a gram-negative pathogenic bacillus. She was initially treated with meropenem, gentamicin, and antiepileptics to control seizures; when antibiotic sensitivity results were available, the antimicrobial regimen was narrowed to cefepime to complete a 21-day course. She was discharged home at age 33 days with early intervention therapies for global hypotonia and close monitoring of her development. From birth until illness onset, the infant was fed exclusively maternal breast milk, both at the breast and expressed. Breast milk was expressed using a personal electric breast pump and was not combined with any additives such as fortifier or infant formula. The breast pump and flanges were wiped with a baby wipe after each use and occasionally cleaned with soap and water. When the bottles and pump parts were cleaned, they were disassembled, hand-scrubbed, and air-dried on a towel next to the sink; they were periodically sanitized either by boiling or in a microwave steam bag. ISDH, in partnership with clinicians from the hospital and CDC, conducted an investigation to identify the source of infection. Items and materials tested included the cerebrospinal fluid isolate, four samples of expressed breast milk, and the breast pump kit and parts from the patient’s home. In addition, kitchen environmental surfaces were sampled using sponges that were submitted for testing. C. sakazakii was isolated from expressed breast milk samples, the breast pump kit, and samples obtained from the sink, drain, and drying area next to the sink. Pulsed field gel electrophoresis (PFGE) was performed on all C. sakazakii isolates using the PulseNet Cronobacter protocol (https://www.cdc.gov/pulsenet/pdf/cronbacter-pfge-protocol-508c.pdf). Environmental isolates were indistinguishable or differed by one band by PFGE from the clinical isolate. C. sakazakii infection is rare and can cause sepsis and severe meningitis, associated with high morbidity and mortality, in infants fed powdered infant formula (). Infection in breast-fed infants is rare but has recently been reported in two preterm neonates in association with contaminated breast pump parts (,). This case demonstrates the potential for invasive infection with this emerging pathogen in healthy full-term neonates fed exclusively maternal breast milk. This organism can grow rapidly in expressed breast milk without added formula (). This case provides additional evidence that, although rare, expressed breast milk contaminated with C. sakazakii can cause life-threatening invasive infection in neonates (,). Although the source of contamination in this case is unknown, as was reported in the other cases, the breast pump kit became contaminated with C. sakazakii (,). Because human milk is the optimal nutrition for neonates, clinicians should proactively support and educate new parents about the importance of breast pump hygiene. Breast pump kits should be taken apart and cleaned either by hand with soap and water or in the dishwasher after every use. Parents should consider sanitizing breast pump kits daily by boiling or steaming, especially if their infant is aged <3 months, was born prematurely, or has a compromised immune system ().
  4 in total

1.  Growth and survival of Enterobacter sakazakii in human breast milk with and without fortifiers as compared to powdered infant formula.

Authors:  Raquel F Lenati; Deborah L O'Connor; Karine C Hébert; Jeffrey M Farber; Franco J Pagotto
Journal:  Int J Food Microbiol       Date:  2007-12-14       Impact factor: 5.277

Review 2.  Cronobacter Species Contamination of Powdered Infant Formula and the Implications for Neonatal Health.

Authors:  Gautam Kalyantanda; Lyudmila Shumyak; Lennox Kenneth Archibald
Journal:  Front Pediatr       Date:  2015-07-02       Impact factor: 3.418

3.  Cronobacter sakazakii Infection from Expressed Breast Milk, Australia.

Authors:  Rowena McMullan; Vidthiya Menon; Alicia G Beukers; Slade O Jensen; Sebastiaan J van Hal; Rebecca Davis
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

4.  Notes from the Field: Cronobacter sakazakii Infection Associated with Feeding Extrinsically Contaminated Expressed Human Milk to a Premature Infant - Pennsylvania, 2016.

Authors:  Anna Bowen; Harold C Wiesenfeld; Jennifer L Kloesz; A William Pasculle; Andrew J Nowalk; LuAnn Brink; Elisa Elliot; Haley Martin; Cheryl L Tarr
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-21       Impact factor: 17.586

  4 in total
  1 in total

1.  Food Safety and Invasive Cronobacter Infections during Early Infancy, 1961-2018.

Authors:  Jonathan Strysko; Jennifer R Cope; Haley Martin; Cheryl Tarr; Kelley Hise; Sarah Collier; Anna Bowen
Journal:  Emerg Infect Dis       Date:  2020-05       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.